Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

314 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Completed

Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT04428788

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Local Institution - 116 Stanford, California, United States
  • Local Institution - 122 Washington D.C., District of Columbia, United States
  • Local Institution - 103 Sarasota, Florida, United States
  • Local Institution - 121 Thomasville, Georgia, United States
View all 19 locations
View Trial Details
Completed

A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan

NCT04034095

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Akita University Hospital Akita, Japan
  • Juntendo University Hospital Bunkyō City, Japan
  • Tokyo Medical and Dental University Hospital Bunkyō City, Japan
  • Chiba University Hospital Chiba, Japan
View all 77 locations
View Trial Details
Completed

Study of Diagnostic Performance of [18F]CTT1057 in BCR

NCT04838613

Conditions
Disease Attributes, Genital Diseases, Genital Diseases, Male, +12 more
Locations
  • Explorer Molecular Imaging center Sacramento, California, United States
  • Novartis Investigative Site Marseille, France
  • Novartis Investigative Site Marseille, France
  • Novartis Investigative Site Nîmes, France
View all 13 locations
View Trial Details
Completed

Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection

NCT04838626

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Explorer Molecular Imaging center Sacramento, California, United States
  • Novartis Investigative Site Marseille, France
  • Novartis Investigative Site Nîmes, France
  • Novartis Investigative Site Pierre-Bénite, France
View all 16 locations
View Trial Details
Completed

Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)

NCT03834506

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of South Alabama, Mitchell Cancer Institute ( Site 0065) Mobile, Alabama, United States
  • St. Joseph Heritage Healthcare ( Site 0069) Fullerton, California, United States
  • University of Southern California Norris Comprehensive Cancer Center ( Site 0061) Los Angeles, California, United States
  • USC Norris Oncology Hematology Newport Beach ( Site 0093) Newport Beach, California, United States
View all 215 locations
View Trial Details

Related conditions